Kadmos Capital

Kadmos Capital is a London-based investment firm specializing in early-stage venture capital investments across cleantech, biotech, and technology-based sectors. The firm currently manages one fund, actively deploying capital into innovative companies within its focus areas. Its portfolio includes companies such as Chemastery, a developer of sustainable chemical processes, and GlycanAge, which focuses on biological age assessment and health diagnostics. Key personnel contributing to the firm's strategic direction include Senior Advisor Jason Kendall and Operating Partner John Gebeily. Kadmos Capital aims to support the growth of disruptive technologies from their early stages, providing both capital and strategic guidance to nurture promising ventures. The firm's founding year and specific founders are not publicly disclosed. Its business model centers on venture capital firm managing funds for early-stage investments, one fund in market since Jan 2022.